Skip to content

← All news

Markets

Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity

1 source ·1 article ·Aug 20, 16:50 UTC Xeris Biopharma

Covered by 1 outlet

All coverage · 1 article

Seeking Alpha ·Aug 20, 16:50 UTC

Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity